More Than 200 Abstracts At ASH And SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current ... (Medical News Today) PDF Print

More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing collaboration with the oncology community.

read more

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.